XML 33 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1

Segment Information (Tables)

3 Months Ended

Mar. 31, 2018

Segment Reporting [Abstract]

Summary of Segment Information

The following table summarizes segment information for the three month periods ended March 31, 2018 and 2017, respectively (in thousands).  

		For the Three-Months Ended March 31,
		2018				2017 (as adjusted)
Net revenues:
Clinical Services		$	56,971			$	52,907
Pharma Services		6,452				4,521
Total Revenue		$	63,423			$	57,428
Cost of revenue:
Clinical Services		$	31,042			$	30,700
Pharma Services		5,078				3,780
Total Cost of Revenue		$	36,120			$	34,480
Gross Profit:
Clinical Services		$	25,929			$	22,207
Pharma Services		1,374				741
Total Gross Profit		$	27,303			$	22,948
Operating expenses:
General and administrative		$	17,067			$	17,018
Research and development		956				862
Sales and marketing		6,775				5,648
Total operating expenses		24,798				23,528
Income (Loss) From Operations		2,505				(580		)
Interest expense, net		1,486				1,364
Other income		(63		)		—
Income (loss) before taxes		1,082				(1,944		)
Income tax (benefit) expense		438				(779		)
Net Income (Loss)		$	644			$	(1,165	)

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8813-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8736-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration